Evaluation the Rationality of Clinical Outcomes of Antibiotic Use and Patterns of Bacterial Resistance to Antibiotics in Children with Pneumonia
Cindy Elvionita(1), Ika Puspita Sari(2*), Titik Nuryastuti(3)
(1) Magister Farmasi Klinik, Fakultas Farmasi, Universitas Gadjah Mada
(2) Departemen Farmakologi dan Farmasi Klinik, Fakultas Farmasi, Universitas Gadjah Mada
(3) Departemen Mikrobiologi Klinik, Fakultas Kedokteran, Kesehatan Masyarakat dan Keperawatan Universitas Gadjah Mada
(*) Corresponding Author
Abstract
Pneumonia is a respiratory infection that attacks the lungs in the lung parenchyma tissue or alveoli. Pneumonia is one of the leading causes of death in children worldwide. Rational use of antibiotics can reduce the risk of antibiotic resistance. This study used observational analytics with a retrospective cohort design. The research subjects were pediatric patients with a diagnosis of pneumonia who were hospitalized at Dr. Sardjito Yogyakarta period 1 January – 31 December 2020. The rationality of the use of antibiotics was evaluated using the Gyssens method. The clinical outcome observed was the patient's condition improving or not improving after 3 to 5 days of antibiotic administration. Chi-Square test to see the relationship of antibiotic rationality to clinical outcomes and multiple logistic regression analysis to analyze the relationship of confounding variables to clinical outcomes. From 141 patients, 211 antibiotic regimens were obtained, with details of 186 empiric antibiotics and 25 definitive antibiotics. The rational use of antibiotics in empirical and definitive antibiotics was 140 regimens (75.27%) and 22 regimens (88%). Total irrational antibiotics (category I-VI) from empirical and definitive antibiotics were 24.73% and 12%, respectively. There is a significant relationship between the rationality of antibiotics with clinical outcomes both empirical and definitive antibiotics (p<0.05). Meanwhile, for confounding variables, there was no significant relationship to the clinical outcome (p>0.05). The most common bacteria were Klebsiella pneumoniae and Acinetobacter baumanii. Klebsiella pneumoniae was the most resistant to ampicillin, ampicillin sulbactam and ceftriaxone antibiotics and Acinetobacter baumanii was the most resistant ampicillin.
Keywords
Full Text:
PDFReferences
Mackenzie G. The definition and classification of pneumonia. pneumonia. 2016;8(1):14, s41479-016-0012-z. doi:10.1186/s41479-016-0012-z
WHO. WORLD HEALTH ORGANIZATION NEW PNEUMONIA KIT 2020 INFORMATION NOTE. Published online 2020.
Kemenkes RI. Profil Kesehatan Indonesia Tahun 2019. Published online 2020.
DinKes DIY. Profil Kesehatan Daerah Istimewa Yogyakarta Tahun 2019. Published online 2020.
Tambun SH, Puspitasari I, Laksanawati IS. Evaluasi Luaran Klinis Terapi Antibiotik pada Pasien Community Acquired Pneumonia Anak Rawat Inap. J Manaj dan Pelayanan Farm. 2019;9(3):213. doi:10.22146/jmpf.47915
Sumiyati. 181-536-1-SM.pdf. Published online Desember 2015.
Nurnajiah M, Rusdi R, Desmawati D. Hubungan Status Gizi dengan Derajat Pneumonia pada Balita di RS. Dr. M. Djamil Padang. JKA. 2016;5(1). doi:10.25077/jka.v5i1.478
Rizqullah N, Putri M, Zulmansyah Z. Hubungan Status Imunisasi Dasar terhadap Pneumonia pada Pasien Balita Rawat Inap di RSIA Respati Tasikmalaya. J Integr Kes Sains. 2021;3(1):19-23. doi:10.29313/jiks.v3i1.7296
Farida Y, Trisna A, Nur D. Study of Antibiotic Use on Pneumonia Patient in Surakarta Referral Hospital. J Pharm Sci Clin Res. 2017;2(01):44. doi:10.20961/jpscr.v2i01.5240
Same RG, Amoah J, Hsu AJ, et al. The Association of Antibiotic Duration With Successful Treatment of Community-Acquired Pneumonia in Children. Journal of the Pediatric Infectious Diseases Society. 2021;10(3):267-273. doi:10.1093/jpids/piaa055
Apriliany F, Umboro RO, Ersalena VF. RASIONALITAS ANTIBIOTIK EMPIRIS PADA PASIEN HOSPITAL ACQUIRED PNEUMONIA (HAP) DI RSUD PROVINSI NTB. :6.
Akademi Farmasi Pemerintah Aceh, Banda Aceh, Indonesia, Gatera VA, Muhtadi A, et al. Association of Pattern of Bacteria Sensitivity During the Empirical Antibiotics Use to the Achievement of Clinical Outcome in Pediatric Patients with Pneumonia. Indones J Clin Pharm. 2014;3(4):127-134. doi:10.15416/ijcp.2014.3.4.12
DOI: https://doi.org/10.22146/farmaseutik.v19i1.76103
Article Metrics
Abstract views : 2177 | views : 3268Refbacks
- There are currently no refbacks.